Probiotics given to pregnant women with GDM and/or obesity in controlled clinical studies decreased fasting glucose levels, increased insulin sensitivity and improved lipid metabolism compared to placebo treatment. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.